Baidu
map

创伤性高凝血症诊疗中国专家共识

2021-04-12 中国医药教育协会 Mil Med Res 发表于上海

对创伤引起的高凝血症的定义、病理生理机制、评估、预防和治疗提出了15条建议

中文标题:

创伤性高凝血症诊疗中国专家共识

英文标题:

Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy

发布机构:

中国医药教育协会

发布日期:

2021-04-12

简要介绍:

创伤性高凝血症(TIC)是由创伤后组织损伤引起的,表现为高凝状态导致血栓栓塞或低凝状态导致不可控制的大量出血。以往关于TIC的研究主要集中在TIC的低凝血性表型引起的出血性凝血病,而最近的研究发现,创伤引起的高凝血性可发生在多达22.2-85.1%的创伤患者中,在这些患者中,高凝血性可使血栓事件和死亡的风险增加2-4倍。因此,中国人民解放军重症医学专业委员会和中华医学教育协会血栓止血与危重症学会共同制定了这份《中国专家共识》,对创伤引起的高凝血症的定义、病理生理机制、评估、预防和治疗提出了15条建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=【医脉通】2021+中国专家共识:创伤后高凝血症的诊断和治疗 (1).pdf)] GetToolGuiderByIdResponse(projectId=1, id=172321c002822e94, title=创伤性高凝血症诊疗中国专家共识, enTitle=Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy, guiderFrom=Mil Med Res, authorId=0, author=, summary=对创伤引起的高凝血症的定义、病理生理机制、评估、预防和治疗提出了15条建议, cover=https://img.medsci.cn/Random/170718015_90777890.jpg, journalId=0, articlesId=null, associationId=1778, associationName=中国医药教育协会, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>创伤性高凝血症(TIC)是由创伤后组织损伤引起的,表现为高凝状态导致血栓栓塞或低凝状态导致不可控制的大量出血。以往关于TIC的研究主要集中在TIC的低凝血性表型引起的出血性凝血病,而最近的研究发现,创伤引起的高凝血性可发生在多达22.2-85.1%的创伤患者中,在这些患者中,高凝血性可使血栓事件和死亡的风险增加2-4倍。因此,中国人民解放军重症医学专业委员会和中华医学教育协会血栓止血与危重症学会共同制定了这份《中国专家共识》,对创伤引起的高凝血症的定义、病理生理机制、评估、预防和治疗提出了15条建议。</p>, tagList=[TagDto(tagId=466054, tagName=创伤性高凝血症)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=27, categoryName=烧伤科, tenant=100), CategoryDto(categoryId=28, categoryName=整形科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=36711, appHits=215, showAppHits=0, pcHits=688, showPcHits=36494, likes=1, shares=20, comments=3, approvalStatus=1, publishedTime=Wed Nov 30 16:21:00 CST 2022, publishedTimeString=2021-04-12, pcVisible=1, appVisible=1, editorId=0, editor=玉在山, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=7, createdBy=null, createdName=玉在山, createdTime=Wed Nov 23 14:25:50 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Fri Jan 05 23:28:00 CST 2024, courseDetails=[], otherVersionGuiders=[OtherVersionToolGuiderDto(projectId=1, id=ea8bc1c002813353, title=《创伤性高凝血症诊疗中国专家共识》解读, enTitle=, guiderPublishedTime=Thu May 20 00:00:00 CST 2021, createdTime=Sat Nov 19 09:30:22 CST 2022)], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=【医脉通】2021+中国专家共识:创伤后高凝血症的诊断和治疗 (1).pdf)])
【医脉通】2021+中国专家共识:创伤后高凝血症的诊断和治疗 (1).pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2166118, encodeId=c7932166118f0, content=<a href='/topic/show?id=a0da10e328f0' target=_blank style='color:#2F92EE;'>#创伤性高凝血症#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=107328, encryptionId=a0da10e328f0, topicName=创伤性高凝血症)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=litao2022, createdTime=Wed Nov 01 15:08:27 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102764, encodeId=52de2102e64aa, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18445445012, createdName=ms1000002074735373, createdTime=Sat Nov 26 16:51:55 CST 2022, time=2022-11-26, status=1, ipAttribution=广东省)]
    2023-11-01 litao2022 来自上海
  2. [GetPortalCommentsPageByObjectIdResponse(id=2166118, encodeId=c7932166118f0, content=<a href='/topic/show?id=a0da10e328f0' target=_blank style='color:#2F92EE;'>#创伤性高凝血症#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=107328, encryptionId=a0da10e328f0, topicName=创伤性高凝血症)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=litao2022, createdTime=Wed Nov 01 15:08:27 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102764, encodeId=52de2102e64aa, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18445445012, createdName=ms1000002074735373, createdTime=Sat Nov 26 16:51:55 CST 2022, time=2022-11-26, status=1, ipAttribution=广东省)]
    2022-11-26 ms1000002074735373 来自广东省

    👍🏻

    0

Baidu
map
Baidu
map
Baidu
map